Authorsâ Reply to Garattini and Freemantle: âValue-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competitionâ
Levaggi, Rosella, Pertile, PaoloJournal:
Applied Health Economics and Health Policy
DOI:
10.1007/s40258-020-00557-w
Date:
February, 2020
File:
PDF, 519 KB
2020